Demanding Biden Step Down Because Hes Too Old Is Wrong. Heres Why
| SER Stock | 6.00 0.47 8.50% |
Slightly above 54% of Serina Therapeutics' retail investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Serina Therapeutics suggests that some traders are interested. Serina Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Serina Therapeutics. Many technical investors use Serina Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Serina |
Demanding Biden Step Down Because Hes Too Old Is Wrong. Heres Why
Read at forbes.com
 |
Serina Therapeutics Fundamental Analysis
We analyze Serina Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Serina Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Serina Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Serina Therapeutics is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Serina Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Serina Therapeutics stock to make a market-neutral strategy. Peer analysis of Serina Therapeutics could also be used in its relative valuation, which is a method of valuing Serina Therapeutics by comparing valuation metrics with similar companies.
Peers
Serina Therapeutics Related Equities
| ORI | Old Republic | 1.12 | ||||
| PLMR | Palomar Holdings | 1.08 | ||||
| TBBB | BBB Foods | 0.86 | ||||
| GO | Grocery Outlet | 0.36 | ||||
| THG | Hanover Insurance | 0.29 | ||||
| AHL-PD | Aspen Insurance | 0.24 | ||||
| SE | Sea | 0.90 | ||||
| AAME | Atlantic American | 1.99 |
Additional Tools for Serina Stock Analysis
When running Serina Therapeutics' price analysis, check to measure Serina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Serina Therapeutics is operating at the current time. Most of Serina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Serina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Serina Therapeutics' price. Additionally, you may evaluate how the addition of Serina Therapeutics to your portfolios can decrease your overall portfolio volatility.